The prevalence of Helicobacter pylori in obese subjects

European Journal of Internal Medicine

Volumn 20, Issue 7, 2009, Pages 695-697

  Arslan, Erol ^a   Atilgan, Halil ^b   Yavaşoǧlu, Irfan ^a  

^a Balmumcu Military Medical Center   (Turkey)

^b BEYTEPE MILITARY HOSPITAL   (Turkey)

Author keywords

Helicobacter pylori prevalence; Lipid profile; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; OBESITY; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 70349761218     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.07.013     Document Type: Article

References (38)

1. MacDonald Jr. K.G. Overview of the epidemiology of obesity and the early history of procedures to remedy morbid obesity. Arch Surg 138 (2003) 357-360
2. World Health Organization. Obesity: Prevention and Managing the Global Epidemic. WHO Obesity Technical Reports Series 894 (2000), WHO, Geneva, Switzerland
3. Oǧuz A., Temizhan A., Abaci A., Kozan O., Erol C., Ongen Z., et al. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults. Anadolu Kardiyol Derg 8 (2008) 401-406
4. Frenck Jr. R.W., and Clemens J. Helicobacter in the developing world. Microbes Infect 5 (2003) 705-713
5. Gasbarrini A., Franceschi F., Gasbarrini G., and Pola P. Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol 9 (1997) 231-233
6. Prelipcean C.C., Mihai C., Gogǎlniceanu P., Mitricǎ D., Drug V.L., and Stanciu C. Extragastric manifestations of Helicobacter pylori infection. Rev Med Chir Soc Med Nat Iasi 111 (2007) 575-583
7. Murray L., Johnston B., Lane A., Harvey I., Donovan J., Nair P., et al. Relationship between body mass and gastroesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol 32 (2003) 645-650
8. Aydemir S., Bayraktaroglu T., Sert M., Sokmen C., Atmaca H., Mungan G., et al. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 50 (2005) 2090-2093
9. Thjodleifsson B., Olafsson I., Gislason D., Gislason T., Jögi R., and Janson C. Infections and obesity: a multinational epidemiological study. Scand J Infect Dis 40 (2008) 381-386
10. Loffeld R.J. Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view. Neth J Med 63 (2005) 344-347
11. Wu M.S., Lee W.J., Wang H.H., Huang S.P., and Lin J.T. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 165 (2005) 1552-1555
12. Kamada T., Hata J., Kusunoki H., Ito M., Tanaka S., Kawamura Y., et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis 37 (2005) 39-43
13. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 449-502
14. Ojetti V., Migneco A., Silveri N.G., Ghirlanda G., Gasbarrini G., and Gasbarrini A. The role of H. pylori infection in diabetes. Curr Diabetes Rev 1 (2005) 343-347
15. Bener A., Micallef R., Afifi M., Derbala M., Al-Mulla H.M., and Usmani M.A. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 18 (2007) 225-229
16. Kopácová M., Bures J., and Koupil I. Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur J Epidemiol 22 (2007) 67-75
17. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., et al. The European Helicobacter Study Group (EHSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56 (2007) 772-781
18. Pronovost A.D., Rose S.L., Pawlak J.W., Robin H., and Schneider R. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results. J Clin Microbiol 32 (1994) 46-50
19. Lamarque D., and Peek Jr. R.M. Pathogenesis of Helicobacter pylori infection. Helicobacter 8 (2003) 21-30
20. Peek Jr. R.M. Pathogenesis of Helicobacter pylori infection. Semin Immunopathol 27 (2005) 197-215
21. Marti A., Marcos A., and Martinez J.A. Obesity and immune function relationships. Obes Rev 2 (2001) 131-140
22. Krishnan E.C., Trost L., Aarons S., and Jewell W.R. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res 33 (1982) 89-97
23. Palmblad J., Hallberg D., and Engsted L. Polymorphonuclear (PMN) function after small intestinal shunt operation for morbid obesity. Br J Haematol 44 (1980) 101-108
24. Cottam D.R., Schaefer P.A., Shaftan G.W., and Angus L.D. Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery. Obes Surg 13 (2003) 49-57
25. Moulin C.M., Marquti I., Peron J.P., Rizzo L.V., and Halpern A. Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metabol 53 (2009) 183-189
26. Falagas M.E., and Kompoti M. Obesity and infection. Lancet Infect Dis 6 (2006) 438-446
27. Devaraj S., Rosenson R.S., and Jialal I. Metabolic syndrome: an appraisal of the proinflamatory and pro-coagulant status. Endocrinol Metab Clin N Am 33 (2004) 431-453
28. Nabipour I., Vahdat K., Jafari S.M., Pazoki R., and Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study. Cardiovasc Diabetol 5 (2006) 25
29. Aslan M., Horoz M., Nazligul Y., Bolukbas C., Bolukbas F.F., Selek S., et al. Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol 4 (2006) 6865-6868
30. Graham D.Y., Malaty H.M., Evans D.G., Evans Jr. D.J., Klein P.D., and Adam E. Epidemiology of Helicobacter pylori in asymptomatic population in United States: effect of age, race, and socioeconomic status. Gastroenterology 100 (1991) 1495-1501
31. Staat M.A., Kruszon-Moran D., McQuillan G.M., and Kaslow R.A. A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J Infect Dis 174 (1996) 1120-1123
32. Malaty H.M., and Graham D.Y. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 35 (1994) 742-745
33. Ceylan A., Kirimi E., Tuncer O., Turkdogan K., Ariyuca S., and Ceylan N. Prevalence of Helicobacter pylori in children and their family members in a district in Turkey. J Health Popul Nutr 25 (2007) 422-427
34. Yucel T., Aygin D., Sen S., and Yucel O. The prevalence of Helicobacter pylori and related factors among university students in Turkey. Jpn J Infect Dis 61 (2008) 179-183
35. Longo-Mbenza B., Nkondi Nsenga J., and Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 121 (2007) 229-238
36. Ioannou G.N., Weiss N.S., and Kearney D.J. Is Helicobacter pylori seropositivity related to body mass index in the United States?. Aliment Pharmacol Ther 21 (2005) 765-772
37. Kamada T., Sugiu K., and Haruma K. Development of obesity and hyperlipidemia after eradication of Helicobacter pylori. Nippon Rinsho 63 (2005) 536-538
38. Kyriazanos I.D., Sfiniadakis I., Gizaris V., Hountis P., Hatziveis K., Dafnopoulou A., et al. The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol 34 (2002) 541-546